Financials • Life Insurance
$263.45 ▲ +2.47
(+0.95%)
MKT CAP: $17.20B • VOL: 364.8K
52W L $180 52W H $272
RGA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $23.70B | $22.11B | $18.57B |
| YoY Revenue Growth % | +7.2% | +19.1% | — |
| Gross Profit | $10.43B | $9.73B | $8.17B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.39B | $846.1M | $1.06B |
| Operating Margin % | 5.9% | 3.8% | 5.7% |
| Net Income (GAAP) | $1.18B | $717.0M | $902.0M |
| EBITDA (Normalized) | $2.25B | $1.64B | $1.73B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.09B | $9.37B | $4.04B |
| Capital Expenditures (CapEx) | $1.07B | $994.8M | $835.5M |
| Free Cash Flow (FCF) | $3.02B | $8.38B | $3.21B |
| FCF Margin % | 12.8% | 37.9% | 17.3% |
| Return on Invested Capital (ROIC %) | 1.5% | 1.2% | 6.2% |
| Cash & Short-Term Equivalents | $4.17B | $3.33B | $2.45B |
| Total Debt (Short + Long Term) | $64.37B | $48.50B | $5.21B |
| Total Stockholders' Equity | $13.46B | $10.82B | $10.69B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR RGA.